Latest Period
Q2 2026
Security Snapshot
Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share (OCS) Institutional Ownership
CUSIP: H5870P102
13F Institutional Holders and Ownership History from Q1 2023 to Q2 2026
Institutions Reporting
59
Shares (Excl. Options)
23,215,628
Price
$13.87
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares, par value CHF 0.01 per share
- Symbol
- OCS on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 23,215,628
- Total 13F value
- $321,980,642
- Portfolio coverage rank
- 0%
- Share change
- +5,527,371
- Value change
- +$47,942,178
- Number of holders
- 59
- Shares outstanding
- 58,900,797
- SEC-reported price per share
- $11.02
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- OCS - Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share is tracked under CUSIP H5870P102.
- 59 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 57 to 59 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $534,701,515 to $321,980,642.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 59 institutions filings for Q2 2026.
Security key
H5870P102
Latest holder period
Q2 2026
13F holders
59
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
OCS full holder history
Oculis Holding AG SEC filings
Oculis Holding AG company facts
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP H5870P102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
OCS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| LSP 7 Cooperative UA | 12% | -14% | $184,808,317 | +$31,838,866 | 6,950,294 | +21% | LSP 7 Cooperatieve U.A. | 31 Mar 2026 |
| Pivotal bioVenture Partners Fund I, L.P. | 4.9% | $49,946,544 | 2,815,476 | Nan Fung Group Holdings Limited | 30 Sep 2025 | |||
| BVCF IV, L.P. | 4.1% | -18% | $73,082,691 | +$7,350,309 | 2,436,902 | +11% | BVCF IV, L.P. | 13 Feb 2026 |
As of 30 Jun 2026, 59 institutional investors reported holding 23,215,628 shares of Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share (OCS). This represents 39% of the company’s total 58,900,797 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
38%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 12% | 6,950,294 | +18% | 11% | $96,400,578 |
| Aberdeen Group plc | 3.7% | 2,159,809 | +24% | 0.04% | $29,956,551 |
| MILLENNIUM MANAGEMENT LLC | 3.5% | 2,042,467 | +124% | 0.02% | $28,329,017 |
| Pivotal bioVenture Partners Investment Advisor LLC | 2.6% | 1,506,250 | -10% | 6.8% | $20,891,688 |
| CITADEL ADVISORS LLC | 1.7% | 987,204 | +512% | 0.01% | $13,692,519 |
| BRAIDWELL LP | 1.4% | 834,183 | 0.43% | $11,570,118 | |
| PERCEPTIVE ADVISORS LLC | 1.4% | 808,827 | +64% | 0.17% | $11,218,430 |
| Saturn V Capital Management LP | 1.2% | 684,880 | +33% | 1.4% | $9,499,286 |
| SR One Capital Management, LP | 1.1% | 641,022 | 0% | 0.86% | $8,890,975 |
| Siren, L.L.C. | 1.1% | 625,000 | 0.18% | $8,668,750 | |
| AMERIPRISE FINANCIAL INC | 1.1% | 619,922 | 0% | $8,598,318 | |
| WELLINGTON MANAGEMENT GROUP LLP | 0.92% | 540,056 | -60% | 0% | $7,490,577 |
| PFM Health Sciences, LP | 0.74% | 436,042 | 0.53% | $6,047,903 | |
| FRANKLIN RESOURCES INC | 0.74% | 434,751 | 0% | $6,029,996 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.68% | 398,980 | 0% | $5,533,853 | |
| MARSHALL WACE, LLP | 0.67% | 394,880 | 0% | $5,476,986 | |
| SYQUANT CAPITAL SAS | 0.64% | 375,000 | +68% | 1.2% | $5,201,000 |
| Nan Fung Group Holdings Ltd | 0.51% | 300,565 | -14% | 3.2% | $4,168,837 |
| Qube Research & Technologies Ltd | 0.45% | 262,113 | +1179% | 0% | $3,635,507 |
| MORGAN STANLEY | 0.38% | 225,083 | +240% | 0% | $3,121,902 |
| Point72 Asset Management, L.P. | 0.37% | 220,403 | +293% | 0% | $3,056,990 |
| Alyeska Investment Group, L.P. | 0.35% | 206,332 | -38% | 0.01% | $2,861,825 |
| Woodline Partners LP | 0.34% | 201,200 | 0% | 0.01% | $2,790,644 |
| Y-Intercept (Hong Kong) Ltd | 0.33% | 192,016 | +558% | 0.05% | $2,663,262 |
| UBS Group AG | 0.31% | 182,415 | +191% | 0% | $2,530,096 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
14
Latest
Q2 2026
Rows shown
1-14 of 14
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 23,215,628 | $321,980,642 | +$47,942,178 | $13.87 | 59 |
| 2026 Q1 | 20,123,708 | $534,701,515 | +$56,496,434 | $26.59 | 57 |
| 2025 Q4 | 18,020,789 | $361,237,998 | +$90,374,744 | $19.97 | 40 |
| 2025 Q3 | 10,893,907 | $191,723,678 | -$2,123,823 | $17.58 | 20 |
| 2025 Q2 | 5,105,646 | $99,100,716 | +$2,469,586 | $19.41 | 23 |
| 2025 Q1 | 4,978,440 | $94,739,711 | +$28,331,355 | $19.03 | 20 |
| 2024 Q4 | 3,493,543 | $59,378,651 | +$8,163,517 | $17.00 | 12 |
| 2024 Q3 | 3,013,203 | $36,946,526 | -$3,838,556 | $12.26 | 10 |
| 2024 Q2 | 3,327,448 | $39,763,128 | -$771,604 | $11.95 | 10 |
| 2024 Q1 | 3,392,028 | $40,873,938 | -$7,013,425 | $12.05 | 9 |
| 2023 Q4 | 3,983,142 | $44,273,231 | +$11,534,877 | $11.12 | 7 |
| 2023 Q3 | 2,916,785 | $32,106,736 | -$2,324,387 | $11.00 | 9 |
| 2023 Q2 | 3,125,204 | $38,536,753 | +$147,595 | $12.33 | 9 |
| 2023 Q1 | 3,123,421 | $23,191,122 | +$23,191,122 | $7.43 | 7 |